Sexual behaviours and risk with women in MSM in sub-Saharan Africa

Marion Fiorentino,Nathan Yanwou,Robinson Gravier-Dumonceau Mazelier,August Eubanks,Perrine Roux,Christian Laurent,Bruno Spire
DOI: https://doi.org/10.1097/qad.0000000000003787
IF: 4.632
2024-02-03
AIDS
Abstract:In 2022, sub-Saharan Africa (SSA) – which comprises Central, East, Southern, and West Africa – had 25.6 million people with HIV (PWH), accounting for 66% of all PWH worldwide [1] . In the rest of the world, HIV epidemics are mostly concentrated in key populations (i.e. sex workers, people who inject drugs, MSM, and transgender women), with prevalence generally below 1% in the general population. In contrast, in East and Southern Africa, the HIV epidemic is considered generalized, with prevalence in the general population ranging from 5 to 30%, with key populations accounting for only 14% of new infections in 2020. In West and Central Africa, the HIV epidemic is generally considered mixed with HIV prevalence in the general population ranging from 1 to 5%, while key populations accounted for 45% of new infections in 2020 [1–4] . These figures highlight the need to investigate the risk of HIV bridging from key populations to the general population in SSA.
immunology,infectious diseases,virology
What problem does this paper attempt to address?